Cue biopharma to present at the piper sandler 32nd annual healthcare conference

Cambridge, mass., nov. 23, 2020 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells within the patient's body, announced today that it participated in a pre-recorded fireside chat as part of the piper sandler 32nd annual virtual healthcare conference, being held on december 1-3, 2020.
CUE Ratings Summary
CUE Quant Ranking